Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer

Andrea Mastrangeli, Claire Danel, Melissa A. Rosenfeld, Leslie Stratford-Perricaudet, Michel Perricaudet, Andrea Pavirani, Jean Pierre Lecocq, Ronald Crystal

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

A variety of pulmonary disorders, including cystic fibrosis, are potentially amenable to treatment in which a therapeutic gene is directly transferred to the bronchial epithelium. This is difficult to accomplish because the majority of airway epithelial cells replicate slowly and/or are terminally differentiated. Adenovirus vectors may circumvent this problem, since they do not require target cell proliferation to express exogenous genes. To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-directed gene transfer, a replication deficient recombinant adenovirus containing the Escherichia coli lacZ (β-galactosidase [β-gal]) gene (Ad.RSVßgal) was used to infect lungs of cotton rats. In contrast to uninfected animals, intratracheal Ad.RSVβgal administration resulted in β-gal activity in lung lysate and cytochemical staining in all cell types forming the airway epithelium. The expression of the exogenous gene was dose-dependent, and the distribution of the β-gal positive airway epithelial cells in Ad.RSVβgal-infected animals was similar to the normal cell differential of the control animals. Thus, a replication deficient recombinant adenovirus can transfer an exogenous gene to all major categories of airway epithelial cells in vivo, suggesting that adenovirus vectors may be an efficient strategy for in vivo gene transfer in airway disorders such as cystic fibrosis.

Original languageEnglish
Pages (from-to)225-234
Number of pages10
JournalJournal of Clinical Investigation
Volume91
Issue number1
DOIs
Publication statusPublished - 1 Jan 1993
Externally publishedYes

Fingerprint

Adenoviridae
Epithelial Cells
Genes
Cystic Fibrosis
Lung
Epithelium
Galactosidases
Sigmodontinae
Lac Operon
Cell Proliferation
Staining and Labeling
Escherichia coli
Gene Expression
Therapeutics

Keywords

  • Cotton rat
  • Cystic fibrosis
  • Gene therapy
  • Lung
  • β-galactosidase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mastrangeli, A., Danel, C., Rosenfeld, M. A., Stratford-Perricaudet, L., Perricaudet, M., Pavirani, A., ... Crystal, R. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. Journal of Clinical Investigation, 91(1), 225-234. https://doi.org/10.1172/JCI116175

Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. / Mastrangeli, Andrea; Danel, Claire; Rosenfeld, Melissa A.; Stratford-Perricaudet, Leslie; Perricaudet, Michel; Pavirani, Andrea; Lecocq, Jean Pierre; Crystal, Ronald.

In: Journal of Clinical Investigation, Vol. 91, No. 1, 01.01.1993, p. 225-234.

Research output: Contribution to journalArticle

Mastrangeli, A, Danel, C, Rosenfeld, MA, Stratford-Perricaudet, L, Perricaudet, M, Pavirani, A, Lecocq, JP & Crystal, R 1993, 'Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer', Journal of Clinical Investigation, vol. 91, no. 1, pp. 225-234. https://doi.org/10.1172/JCI116175
Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet L, Perricaudet M, Pavirani A et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. Journal of Clinical Investigation. 1993 Jan 1;91(1):225-234. https://doi.org/10.1172/JCI116175
Mastrangeli, Andrea ; Danel, Claire ; Rosenfeld, Melissa A. ; Stratford-Perricaudet, Leslie ; Perricaudet, Michel ; Pavirani, Andrea ; Lecocq, Jean Pierre ; Crystal, Ronald. / Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. In: Journal of Clinical Investigation. 1993 ; Vol. 91, No. 1. pp. 225-234.
@article{a639187288714b4abb5bd1b936f91f72,
title = "Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer",
abstract = "A variety of pulmonary disorders, including cystic fibrosis, are potentially amenable to treatment in which a therapeutic gene is directly transferred to the bronchial epithelium. This is difficult to accomplish because the majority of airway epithelial cells replicate slowly and/or are terminally differentiated. Adenovirus vectors may circumvent this problem, since they do not require target cell proliferation to express exogenous genes. To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-directed gene transfer, a replication deficient recombinant adenovirus containing the Escherichia coli lacZ (β-galactosidase [β-gal]) gene (Ad.RSV{\ss}gal) was used to infect lungs of cotton rats. In contrast to uninfected animals, intratracheal Ad.RSVβgal administration resulted in β-gal activity in lung lysate and cytochemical staining in all cell types forming the airway epithelium. The expression of the exogenous gene was dose-dependent, and the distribution of the β-gal positive airway epithelial cells in Ad.RSVβgal-infected animals was similar to the normal cell differential of the control animals. Thus, a replication deficient recombinant adenovirus can transfer an exogenous gene to all major categories of airway epithelial cells in vivo, suggesting that adenovirus vectors may be an efficient strategy for in vivo gene transfer in airway disorders such as cystic fibrosis.",
keywords = "Cotton rat, Cystic fibrosis, Gene therapy, Lung, β-galactosidase",
author = "Andrea Mastrangeli and Claire Danel and Rosenfeld, {Melissa A.} and Leslie Stratford-Perricaudet and Michel Perricaudet and Andrea Pavirani and Lecocq, {Jean Pierre} and Ronald Crystal",
year = "1993",
month = "1",
day = "1",
doi = "10.1172/JCI116175",
language = "English",
volume = "91",
pages = "225--234",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer

AU - Mastrangeli, Andrea

AU - Danel, Claire

AU - Rosenfeld, Melissa A.

AU - Stratford-Perricaudet, Leslie

AU - Perricaudet, Michel

AU - Pavirani, Andrea

AU - Lecocq, Jean Pierre

AU - Crystal, Ronald

PY - 1993/1/1

Y1 - 1993/1/1

N2 - A variety of pulmonary disorders, including cystic fibrosis, are potentially amenable to treatment in which a therapeutic gene is directly transferred to the bronchial epithelium. This is difficult to accomplish because the majority of airway epithelial cells replicate slowly and/or are terminally differentiated. Adenovirus vectors may circumvent this problem, since they do not require target cell proliferation to express exogenous genes. To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-directed gene transfer, a replication deficient recombinant adenovirus containing the Escherichia coli lacZ (β-galactosidase [β-gal]) gene (Ad.RSVßgal) was used to infect lungs of cotton rats. In contrast to uninfected animals, intratracheal Ad.RSVβgal administration resulted in β-gal activity in lung lysate and cytochemical staining in all cell types forming the airway epithelium. The expression of the exogenous gene was dose-dependent, and the distribution of the β-gal positive airway epithelial cells in Ad.RSVβgal-infected animals was similar to the normal cell differential of the control animals. Thus, a replication deficient recombinant adenovirus can transfer an exogenous gene to all major categories of airway epithelial cells in vivo, suggesting that adenovirus vectors may be an efficient strategy for in vivo gene transfer in airway disorders such as cystic fibrosis.

AB - A variety of pulmonary disorders, including cystic fibrosis, are potentially amenable to treatment in which a therapeutic gene is directly transferred to the bronchial epithelium. This is difficult to accomplish because the majority of airway epithelial cells replicate slowly and/or are terminally differentiated. Adenovirus vectors may circumvent this problem, since they do not require target cell proliferation to express exogenous genes. To evaluate the diversity of airway epithelial cell targets for in vivo adenovirus-directed gene transfer, a replication deficient recombinant adenovirus containing the Escherichia coli lacZ (β-galactosidase [β-gal]) gene (Ad.RSVßgal) was used to infect lungs of cotton rats. In contrast to uninfected animals, intratracheal Ad.RSVβgal administration resulted in β-gal activity in lung lysate and cytochemical staining in all cell types forming the airway epithelium. The expression of the exogenous gene was dose-dependent, and the distribution of the β-gal positive airway epithelial cells in Ad.RSVβgal-infected animals was similar to the normal cell differential of the control animals. Thus, a replication deficient recombinant adenovirus can transfer an exogenous gene to all major categories of airway epithelial cells in vivo, suggesting that adenovirus vectors may be an efficient strategy for in vivo gene transfer in airway disorders such as cystic fibrosis.

KW - Cotton rat

KW - Cystic fibrosis

KW - Gene therapy

KW - Lung

KW - β-galactosidase

UR - http://www.scopus.com/inward/record.url?scp=0027448270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027448270&partnerID=8YFLogxK

U2 - 10.1172/JCI116175

DO - 10.1172/JCI116175

M3 - Article

C2 - 8423221

AN - SCOPUS:0027448270

VL - 91

SP - 225

EP - 234

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -